Follow
Megan L. Shaw
Megan L. Shaw
Verified email at uwc.ac.za
Title
Cited by
Cited by
Year
Human host factors required for influenza virus replication
R König, S Stertz, Y Zhou, A Inoue, HH Hoffmann, S Bhattacharyya, ...
Nature 463 (7282), 813-817, 2010
9642010
Meta-and orthogonal integration of influenza “OMICs” data defines a role for UBR4 in virus budding
S Tripathi, MO Pohl, Y Zhou, A Rodriguez-Frandsen, G Wang, DA Stein, ...
Cell host & microbe 18 (6), 723-735, 2015
9042015
Ebola virus VP24 binds karyopherin α1 and blocks STAT1 nuclear accumulation
SP Reid, LW Leung, AL Hartman, O Martinez, ML Shaw, C Carbonnelle, ...
Journal of virology 80 (11), 5156-5167, 2006
5562006
Newcastle disease virus (NDV)-based assay demonstrates interferon-antagonist activity for the NDV V protein and the Nipah virus V, W, and C proteins
MS Park, ML Shaw, J Munoz-Jordan, JF Cros, T Nakaya, N Bouvier, ...
Journal of virology 77 (2), 1501-1511, 2003
4562003
Cellular proteins in influenza virus particles
ML Shaw, KL Stone, CM Colangelo, EE Gulcicek, P Palese
PLoS pathogens 4 (6), e1000085, 2008
4242008
Transcription elongation can affect genome 3D structure
S Heinz, L Texari, MGB Hayes, M Urbanowski, MW Chang, N Givarkes, ...
Cell 174 (6), 1522-1536. e22, 2018
3722018
Orthomyxoviridae
ML Shaw, P Palese
Fields virology 1, 1151-1185, 2013
3252013
Breakthrough infections with SARS-CoV-2 omicron despite mRNA vaccine booster dose
C Kuhlmann, CK Mayer, M Claassen, T Maponga, WA Burgers, R Keeton, ...
The Lancet 399 (10325), 625-626, 2022
3042022
Nipah virus V and W proteins have a common STAT1-binding domain yet inhibit STAT1 activation from the cytoplasmic and nuclear compartments, respectively
ML Shaw, A García-Sastre, P Palese, CF Basler
Journal of virology 78 (11), 5633-5641, 2004
2602004
Broad-spectrum antiviral that interferes with de novo pyrimidine biosynthesis
HH Hoffmann, A Kunz, VA Simon, P Palese, ML Shaw
Proceedings of the National Academy of Sciences 108 (14), 5777-5782, 2011
2542011
Nuclear localization of the Nipah virus W protein allows for inhibition of both virus-and toll-like receptor 3-triggered signaling pathways
ML Shaw, WB Cardenas, D Zamarin, P Palese, CF Basler
Journal of virology 79 (10), 6078-6088, 2005
2262005
Functional landscape of SARS-CoV-2 cellular restriction
L Martin-Sancho, MK Lewinski, L Pache, CA Stoneham, X Yin, ME Becker, ...
Molecular cell 81 (12), 2656-2668. e8, 2021
1722021
Baloxavir marboxil: the new influenza drug on the market
R O’Hanlon, ML Shaw
Current opinion in virology 35, 14-18, 2019
1502019
Nipah virus sequesters inactive STAT1 in the nucleus via a P gene-encoded mechanism
MJ Ciancanelli, VA Volchkova, ML Shaw, VE Volchkov, CF Basler
Journal of virology 83 (16), 7828-7841, 2009
1372009
A Sendai virus-derived RNA agonist of RIG-I as a virus vaccine adjuvant
L Martinez-Gil, PH Goff, R Hai, A Garcia-Sastre, ML Shaw, P Palese
Journal of virology 87 (3), 1290-1300, 2013
1362013
Modulation of influenza virus replication by alteration of sodium ion transport and protein kinase C activity
HH Hoffmann, P Palese, ML Shaw
Antiviral research 80 (2), 124-134, 2008
1192008
Uncovering the global host cell requirements for influenza virus replication via RNAi screening
S Stertz, ML Shaw
Microbes and infection 13 (5), 516-525, 2011
1072011
Nipah virus edits its P gene at high frequency to express the V and W proteins
S Kulkarni, V Volchkova, CF Basler, P Palese, VE Volchkov, ML Shaw
Journal of virology 83 (8), 3982-3987, 2009
912009
Fields virology
P Palese, ML Shaw
Orthomyxoviridae: The Viruses and Their Replication, 5th edn, Philadelphia …, 2007
912007
Paramyxovirus V proteins interact with the RIG-I/TRIM25 regulatory complex and inhibit RIG-I signaling
MT Sanchez-Aparicio, LJ Feinman, A García-Sastre, ML Shaw
Journal of virology 92 (6), 10.1128/jvi. 01960-17, 2018
822018
The system can't perform the operation now. Try again later.
Articles 1–20